Clinical Trial Update: Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224) [Phase 1]

View source ↗

Summary

A Phase 1 trial of Erwinase for relapsed/refractory acute lymphoblastic leukemia, including patients with allergies to PEGylated or native E. coli asparaginase,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Erwinase (L-asparaginase from Erwinia chrysanthemi)

Snippet

Sponsor: Therapeutic Advances in Childhood Leukemia Consortium | Conditions: Relapsed Acute Lymphoblastic Leukemia, Allergy to PEG e.Coli Asparaginase | Phase 1 | Status: TERMINATED | Results posted: 2019-02-19